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21. General information
Unless otherwise noted, chemicals and solvents were purchased with the highest purity grade 
available and were used without further purification. Purification of products was conducted by 
column chromatography on silica gel (200-300 mesh, from Qingdao, China). NMR spectra were 
measured on a Bruker ARX400 (1H at 400 MHz, 13C at 101 MHz, 19F at 471 MHz) magnetic 
resonance spectrometer. Chemical shifts (δ) are reported in ppm using tetramethylsilane as internal 
standard (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, td = triplet of 
doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, m = multiplet), and coupling 
constants (J) were reported in Hertz (Hz). Infrared spectra were recorded on a Thermal Fisher 
Nicolet iS50 Fourier transform spectrometer (FT-IR) and were reported in wave numbers (cm-1). 
HRMS data were obtained on a VG ZAB-HS mass spectrometer, Brucker Apex IV FTMS 
spectrometer.
Materials: Pt electrodes were purchased from Tianjin Aida Corp. The potentiostat was purchased 
from JD.com, ITECH IT6720. Gram-scale reaction was carried out by using IKA Electrasyn 2.0.
The starting materials 1 were synthesized as reported by Liu[1] The starting materials 2 were 
synthesized as reported also by Liu[2]. The starting materials 3 were synthesized as reported by 
Nevado[3].
32. Equipments and experiments setup pictures
Figure S1. Pt net electrodes
Figure S2. The potentiostat
Figure S3. 0.3 mmol scale electrolysis experiment
43. Cyclic voltammetry and 19F NMR studies
Cyclic voltammetry (CV) experiments were conducted in a 50 mL glass vial fitted with an L-type 
glassy carbon working electrode, a saturated calomel electrode (SCE) reference electrode, and a 
platinum wire counter electrode. The solution of interest was sparged with nitrogen for 3-5 minutes 
before data collection.
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(a) CF3SO2Na in 1,4-dioxane/H2O











Figure S4. 19F NMR (471 MHz) spectra of (a) CF3SO2Na in 1,4-dioxane/H2O solution and (b) 
electrochemical reaction mixture of CF3SO2Na and MnBr2•4H2O in 1,4-dioxane/H2O at 60 oC after 
passing 1.1 F/mol electricity.
4. Compound data
General Procedure for the 0.3 mmol scale electrochemical experiments: To a 15 mL test tube with 
a stir bar was charged with 0.3 mmol 1, 0.45 mmol Langlois reagent and 0.06 mmol MnBr2, 
followed by 3 mL dioxane and 0.5 mL aqueous H3PO4 solution (1.2 M, 0.6 mmol). Two platinum 
net electrodes (1.0 cm × 1.0 cm) were set up in the tube. Make sure that the electrodes be totally 
immersed. The resulting mixture was electrolyzed at constant current mode with a current of 10 mA 
under ambient temperature. The reaction was monitored by TLC or GC. If the reaction was not 
completed after 3 hours, add 0.45 mmol Langlois reagent. Upon completion, the reaction mixture 
was concentrated under reduced pressure. The residue was chromatographed through silica gel 
eluting with PE/EA to give the desired product 2, 4, 6.
1,3-Dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2a). White solid, 
49mg, 67%.  1H NMR (400 MHz, CDCl3): δ 7.31 (td, J = 7.7, 1.3 Hz, 
1H), 7.27 (d, J = 7.3 Hz, 1H), 7.09 (td, J = 7.5, 1.0 Hz, 1H), 6.88 (d, J = 





515.2, 10.5 Hz, 1H), 1.41 (s, 3H). 13C NMR (101 MHz, CDCl3): 178.50, 142.88, 131.01, 128.54, 
125.27 (q, J = 278.1 Hz), 123.56, 122.66, 108.47, 44.38 (q, J = 2.1 Hz), 40.64 (q, J = 28.5 Hz), 
26.42, 25.01.[4] 
1,3,5-Trimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2b). White solid, 
58mg, 75%. 1H NMR (400 MHz, CDCl3): δ 7.11 (ddd, J = 7.9, 1.7, 0.8 
Hz, 1H), 7.08 (d, J = 1.6 Hz, 1H), 6.77 (d, J = 7.9 Hz, 1H), 3.21 (s, 3H), 
2.81 (dq, J = 15.1, 10.8 Hz, 1H), 2.63 (dq, J = 15.1, 10.5 Hz, 1H), 2.35 
(s, 3H), 1.39 (s, 3H). 13C NMR (101 MHz, CDCl3): 178.43, 140.48, 
132.18, 131.08, 128.77, 126.67, 125.29 (q, J = 278.2 Hz), 124.34, 
108.17, 44.43 (q, J = 2.2 Hz), 40.62 (q, J = 28.0 Hz), 26.44, 25.04, 
21.12.[4] 
1,3-Dimethyl-3-(2,2,2-trifluoroethyl)-5-
(trifluoromethyl)indolin-2-one (2c). White solid, 72mg, 77%. 1H 
NMR (400 MHz, CDCl3): δ 7.66 – 7.57 (m, 1H), 7.50 (d, J = 1.7 
Hz, 1H), 6.97 (d, J = 8.2 Hz, 1H), 3.28 (s, 3H), 2.87 (dq, J = 15.2, 
10.6 Hz, 1H), 2.69 (dq, J = 15.2, 10.3 Hz, 1H), 1.44 (s, 3H). 13C 
NMR (101 MHz, CDCl3): 178.36, 145.86, 131.54, 126.38 (q, J 
= 4.3 Hz), 125.01 (q, J = 32.5 Hz), 125.00 (q, J = 276.6Hz), 
124.28 (q, J = 269.9 Hz), 120.66 (q, J = 1.7 Hz), 108.30, 44.32 (q, J = 2.7 Hz), 40.57 (q, J = 28.5 
Hz), 26.63, 24.89.[5]
5-Fluoro-1,3-dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one 
(2d). White solid, 58mg, 74%. 1H NMR (400 MHz, CDCl3): δ 
7.02 (m, 2H), 6.81 (dd, J = 9.2, 4.2 Hz, 1H), 3.23 (s, 3H), 2.93 – 
2.75 (m, 1H), 2.72 – 2.55 (m, 1H), 1.41 (s, 3H). 13C NMR (101 
MHz, CDCl3): 178.1, 159.2 (d, J = 239.5), 138.8 (d, J = 2.0 Hz), 
132.6 (d, J = 7.7 Hz), 125.1 (q, J = 277.9 Hz), 114.8 (d, J = 23.6 
Hz), 111.7 (dd, J = 1.5 Hz, 24.7 Hz), 108.9 (d, J = 8.1). 44.8, 40.5 
(q, J = 28.4 Hz), 26.5, 24.9 (d, J = 10.0 Hz).[4]
5-Chloro-1,3-dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one 
(2e). White solid, 69mg, 83%. 1H NMR (400 MHz, CDCl3): δ 
7.29 (dd, J = 8.3, 2.1 Hz, 1H), 7.24 (d, J = 2.0 Hz, 1H), 6.81 (d, 
J = 8.3 Hz, 1H), 3.22 (s, 3H), 2.83 (dd, J = 15.2, 10.7 Hz, 1H), 
2.63 (dd, J = 15.2, 10.4 Hz, 1H), 1.41 (s, 3H). 13C NMR (101 
MHz, CDCl3): 177.9, 141.4, 132.6, 128.5, 128.1, 125.0 (q, J = 
276.3 Hz), 124.0 (d, J = 1.6 Hz), 109.4, 44.5 (d, J = 1.9 Hz), 40.5 
(q, J = 28.3 Hz), 26.6, 24.9.[4]
5-Bromo-1,3-dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2f). 
White solid, 52mg, 54%.  1H NMR (400 MHz, CDCl3): δ 7.44 

























68.3 Hz, 1H), 3.22 (s, 3H), 2.83 (dq, J = 15.2, 10.6 Hz, 1H), 2.63 (dq, J = 15.2, 10.4 Hz, 1H), 1.41 
(s, 3H). 13C NMR (101 MHz, CDCl3): 177.83, 141.95, 133.05, 131.45, 126.84, 125.05(q, J = 276.3), 
115.34, 109.93, 44.54 (q, J = 2.3), 40.60(q, J = 28.2), 26.55, 24.95.[4]
5-Iodo-1,3-dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2g). 
Pale yellow solid, 33mg, 30%. 1H NMR (400 MHz, CDCl3): δ 
7.63 (dd, J = 8.2, 1.7 Hz, 1H), 7.54 (d, J = 1.8 Hz, 1H), 6.67 (d, 
J = 8.2 Hz, 1H), 3.21 (s, 3H), 2.82 (dq, J = 15.2, 10.6 Hz, 1H), 
2.62 (dq, J = 15.2, 10.4 Hz, 1H), 1.40 (s, 3H). 13C NMR (101 
MHz, CDCl3): 177.67, 142.63, 137.41, 133.39, 132.38, 125.05 
(q, J = 278.1 Hz), 110.53, 85.09, 77.25, 44.36 (q, J = 2.1 Hz), 
40.59 (q, J = 28.4 Hz), 26.51, 24.97.[4]
1,3-Dimethyl-2-oxo-3-(2,2,2-trifluoroethyl)indoline-5-
carbonitrile (2h). White solid, 49mg, 61%. 1H NMR (400 
MHz, CDCl3): δ 7.66 (dd, J = 8.2, 1.7 Hz, 1H), 7.54 (d, J = 1.6 
Hz, 1H), 6.98 (d, J = 8.2 Hz, 1H), 3.28 (s, 3H), 2.88 (dq, J = 15.3, 
10.6 Hz, 1H), 2.70 (dq, J = 15.2, 10.3 Hz, 1H), 1.44 (s, 3H). 13C 
NMR (101 MHz, CDCl3): 178.09, 146.74, 133.88, 131.99, 
127.02 (q, J = 1.6 Hz), 124.89 (q, J = 278.0 Hz), 118.99, 109.02, 
105.93, 44.15 (q, J = 2.2 Hz), 40.51 (q, J = 28.6 Hz), 26.70, 24.85.[6]
Ethyl 1,3-dimethyl-2-oxo-3-(2,2,2-trifluoroethyl)indoline-5-
carboxylate (2i). White solid, 58mg, 61%. 1H NMR (400 MHz, 
CDCl3): δ 8.08 (dd, J = 8.2, 1.7 Hz, 1H), 7.94 (d, J = 1.7 Hz, 1H), 
6.93 (d, J = 8.3 Hz, 1H), 4.38 (q, J = 7.3 Hz, 2H), 3.28 (s, 3H), 
2.88 (dq, J = 15.2, 10.6 Hz, 1H), 2.71 (dq, J = 15.2, 10.3 Hz, 1H), 
1.53 – 1.34 (m, 6H). 13C NMR (101 MHz, CDCl3): 178.70, 
166.25, 146.88, 131.16, 130.92,, 125.06, 125.02 (q, J = 278.2 
Hz)124.74, 108.00, 61.00, 44.18 (q, J = 2.2 Hz), 40.65 (q, J = 28.2 Hz), 26.64, 25.03, 14.38.[6]
5-Butyl-1,3-dimethyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2j). 
White solid, 64mg, 71%. 1H NMR (400 MHz, CDCl3): δ 7.11 
(dd, J = 7.9, 1.7 Hz, 1H), 7.08 (s, 1H), 6.79 (d, J = 7.9 Hz, 1H), 
3.22 (s, 3H), 2.81 (dq, J = 15.2, 10.8 Hz, 1H), 2.72 – 2.55 (m, 
3H), 1.65 – 1.52 (m, 2H), 1.40 (s, 3H), 1.33 (dt, J = 14.6, 7.4 Hz, 
2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3): 
178.53, 140.64, 137.46, 130.95, 128.21, 125.30 (q, J = 278.5 
Hz), 123.77, 108.14, 44.46 (q, J = 2.4 Hz), 40.65 (q, J = 28.3 Hz), 35.36, 34.02, 26.45, 25.02, 22.18, 
13.94.[5]
1-Methyl-1-(2,2,2-trifluoroethyl)-5,6-dihydro-1H-
pyrrolo[3,2,1-iJ]quinolin-2(4H)-one (2k). White solid, 54mg, 

























77.06 (dd, J = 7.7, 1.1 Hz, 1H), 6.97 (t, J = 7.5 Hz, 1H), 3.76 – 3.69 (m, 2H), 2.85 – 2.71 (m, 3H), 
2.65 (dq, J = 15.2, 10.5 Hz, 1H), 2.06 – 1.97 (m, 2H), 1.42 (s, 3H). 13C NMR (101 MHz, CDCl3): 
177.37, 138.64, 129.69, 127.29, 125.43 (q, J = 276 Hz),122.09, 121.48, 120.52, 45.65 (q, J = 1.9 
Hz), 40.46 (q, J = 1.9 Hz), 39.06, 24.61, 24.57, 21.13.[4]
1-Ethyl-3-methyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2l). White 
solid, 53mg, 69%. 1H NMR (400 MHz, CDCl3): δ 7.30 (td, J = 7.7, 
1.3 Hz, 1H), 7.26 (t, J = 3.7 Hz, 1H), 7.08 (td, J = 7.6, 1.0 Hz, 1H), 6.90 
(d, J = 7.8 Hz, 1H), 3.88 (dq, J = 14.5, 7.3 Hz, 1H), 3.69 (dq, J = 14.3, 
7.2 Hz, 1H), 2.84 (dq, J = 15.1, 10.7 Hz, 1H), 2.64 (dq, J = 15.1, 10.5 
Hz, 1H), 1.40 (s, 3H), 1.25 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): 178.08, 141. 92, 31.23, 128.45, 125.26 (q, J = 278.3 Hz), 
123.72, 122.39, 108.61, 44.29 (q, J = 1.9 Hz), 40.68 (q, J = 28.3 Hz), 34.78, 25.12, 12.26.[7]
1-Ethyl-3-methyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2m). White 
solid, 63mg, 77%. 1H NMR (400 MHz, CDCl3): δ 7.30 – 7.22 (m, 2H), 
7.09 – 7.01 (m, 2H), 4.63 (hept, J = 7.0 Hz, 1H), 2.84 (dq, J = 15.1, 10.7 
Hz, 1H), 2.62 (dq, J = 15.1, 10.4 Hz, 1H), 1.48 (dd, J = 7.1, 5.0 Hz, 6H), 
1.38 (s, 3H). 13C NMR (101 MHz, CDCl3): 178.16, 141.57, 131.41, 
128.20, 125.26 (q, J = 278.4 Hz), 123.74, 122.02, 110.14, 44.08 (q, J = 
1.8 Hz), 43.98, 40.78 (q, J = 28.1 Hz), 25.33, 19.21, 19.03.[7]
3-Methyl-1-phenyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2n). White 
solid, 61mg, 67%. 1H NMR (400 MHz, CDCl3): δ 7.53 (dd, J = 8.6, 6.6 
Hz, 2H), 7.45 – 7.36 (m, 3H), 7.32 (dd, J = 7.4, 1.2 Hz, 1H), 7.26 – 7.19 
(m, 1H), 7.12 (td, J = 7.6, 1.1 Hz, 1H), 6.87 – 6.80 (m, 1H), 2.96 (dq, J 
= 15.1, 10.7 Hz, 1H), 2.72 (dq, J = 15.1, 10.4 Hz, 1H), 1.53 (s, 3H). 13C 
NMR (101 MHz, CDCl3): 178.00, 142.96, 134.35, 130.69, 129.70, 
128.47, 128.29, 126.64, 125.33 (q, J = 278.3 Hz), 123.79, 123.09, 
109.79, 44.53 (q, J = 2.2 Hz), 41.09 (q, J = 28.2 Hz), 25.47.[4]
1-(2-Hydroxyethyl)-3-methyl-3-(2,2,2-trifluoroethyl)indolin-2-one (2o). 
White solid, 58mg, 71%. 1H NMR (400 MHz, CDCl3): δ 7.33 – 7.28 
(m, 1H), 7.26 (d, J = 7.1 Hz, 1H), 7.09 (td, J = 7.6, 0.9 Hz, 1H), 6.98 (d, 
J = 7.9 Hz, 1H), 4.01 – 3.80 (m, 4H), 2.85 (dq, J = 15.2, 10.7 Hz, 1H), 
2.74 – 2.56 (m, 2H), 1.41 (s, 3H). 13C NMR (101 MHz, CDCl3): 179.59, 
142.25, 130.98, 128.56, 125.23 (q, J = 278.6 Hz), 123.68, 122.82, 
109.01, 60.32, 44.37 (q, J = 2.6 Hz), 43.08, 40.70 (q, J = 28.0 Hz), 25.19.
Ethyl 1-methyl-3-(2,2,2-trifluoroethyl)indoline-3-carboxylate (4a). 
White solid, 62mg, 66%. 1H NMR (400 MHz, CDCl3): δ 8.21 (d, J = 
8.1 Hz, 1H), 7.38 – 7.34 (m, 1H), 7.31 (td, J = 7.8, 1.3 Hz, 1H), 7.08 (td, 
J = 7.6, 1.1 Hz, 1H), 4.86 (d, J = 11.2 Hz, 1H), 4.21 (qd, J = 7.1, 1.7 Hz, 
























82.48 (m, 1H), 2.30 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): 170.18, 168.51, 
141.83, 130.33, 130.13, 125.52 (q, J = 278.4 Hz), 124.11, 123.76, 117.53, 62.52, 55.13, 50.91, 41.03 
(q, J = 28.0 Hz), 24.22, 13.88. 19 F NMR (471 MHz, CDCl3): -61.73. IR: ν = 2986, 1733, 1667, 
1481, 1402, 1255, 1219, 1129, 754cm-1. HRMS (ESI): calcd for C15H17F3NO3+ [M+H]+: 316.1160; 
found: 316.1160.
Ethyl 1-acetyl-5-fluoro-3-(2,2,2-trifluoroethyl)indoline-3-carboxylate 
(4b). White solid, 62mg, 62%. 1H NMR (400 MHz, CDCl3): δ 8.18 
(dd, J = 8.9, 4.8 Hz, 1H), 7.07 (dd, J = 8.1, 2.7 Hz, 1H), 7.01 (td, J = 
8.8, 2.7 Hz, 1H), 4.87 (d, J = 11.2 Hz, 1H), 4.23 (qq, J = 7.0, 3.6 Hz, 
2H), 4.08 (d, J = 11.2 Hz, 1H), 3.27 (dq, J = 15.2, 10.6 Hz, 1H), 2.57 
(dq, J = 15.2, 10.0 Hz, 1H), 2.29 (s, 3H), 1.29 (s, 3H). 13C NMR (101 
MHz, CDCl3): 169.66, 168.25, 159.27 (d, J = 243.9 Hz), 138.06, 131.92 
(d, J = 8.0 Hz), 125.32 (q, J = 278.7 Hz), 118.51 (d, J = 8.0 Hz), 116.67 (d, J = 22.7 Hz), 111.21 (d, 
J = 25.2 Hz), 62.81, 55.33, 50.84, 40.95 (q, J = 28.4 Hz), 23.95, 13.87. 19 F NMR (471 MHz, CDCl3): 
-61.75, -117.69. IR: ν =2986, 2159, 1738, 1668, 1487, 1401, 1318, 1257, 1224, 1149, 1128 cm-1. 
HRMS (ESI): calcd for C15H16F4NO3+ [M+H]+: 334.1066; found: 334.1061.
Ethyl 1-acetyl-5-chloro-3-(2,2,2-trifluoroethyl)indoline-3-carboxylate 
(4b). White solid, 80mg, 79%. 1H NMR (400 MHz, CDCl3): δ 8.15 (d, 
J = 8.6 Hz, 1H), 7.32 (d, J = 2.2 Hz, 1H), 7.27 (dd, J = 8.7, 2.2 Hz, 1H), 
4.86 (d, J = 11.2 Hz, 1H), 4.24 (qq, J = 7.5, 3.6 Hz, 2H), 4.07 (d, J = 
11.2 Hz, 1H), 3.29 (dq, J = 15.2, 10.6 Hz, 1H), 2.56 (dq, J = 15.2, 10.0 
Hz, 1H), 2.29 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H) 13C NMR (101 MHz, 
CDCl3): 169.63, 168.48, 140.51, 131.97, 130.15, 128.96, 125.31 (d, J 
= 278.6 Hz), 124.08, 118.46, 62.85, 55.24, 50.83, 40.98 (q, J = 28.3 Hz), 24.06, 13.88. 19 F NMR 
(471 MHz, CDCl3): -61.72. IR: ν = 2922, 2159, 1734, 1700, 1477, 1393, 1255, 1219, 1171, 1133, 
826cm-1. HRMS (ESI): calcd for C15H16ClF3NO3+ [M+H]+: 350.0771; found: 350.0771.
Ethyl 1-acetyl-5-bromo-3-(2,2,2-trifluoroethyl)indoline-3-carboxylate 
(4e). Pale white solid, 70mg, 59%. 1H NMR (400 MHz, CDCl3): δ 8.10 
(d, J = 8.6 Hz, 1H), 7.46 (d, J = 2.0 Hz, 1H), 7.42 (dd, J = 8.7, 2.1 Hz, 
1H), 4.85 (d, J = 11.2 Hz, 1H), 4.24 (qq, J = 6.8, 3.6 Hz, 2H), 4.07 (d, 
J = 11.2 Hz, 1H), 3.29 (dq, J = 15.3, 10.6 Hz, 1H), 2.56 (dq, J = 15.3, 
10.0 Hz, 1H), 2.29 (s, 3H), 1.30 (d, J = 7.1 Hz, 3H). 13C NMR (101 
MHz, CDCl3): 169.63, 168.53, 140.99, 133.07, 132.32, 126.97, 125.31 
(d, J = 278.7 Hz), 118.89, 116.25, 62.87, 55.18, 50.79, 41.00 (q, J = 28.5 Hz), 24.11, 13.89. 19 F 
NMR (471 MHz, CDCl3): -61.71. IR: ν = 2986, 2161, 1734, 1669, 1475, 1392, 1255, 1218, 1132, 
825cm-1. HRMS (ESI): calcd for C15H16BrF3NO3+ [M+H]+: 361.0266; found: 361.0261.
Ethyl 1-acetyl-5-methyl-3-(2,2,2-trifluoroethyl)indoline-3-carboxylate 
(4e). White solid, 68mg, 69%. 1H NMR (400 MHz, CDCl3): δ 8.07 
(d, J = 8.2 Hz, 1H), 7.13 (d, J = 1.7 Hz, 1H), 7.13 – 7.09 (m, 1H), 4.83 
























93.34 (dq, J = 15.3, 10.8 Hz, 1H), 2.52 (dq, J = 15.3, 10.1 Hz, 1H), 2.33 (s, 3H), 2.28 (s, 3H), 1.27 
(t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): 170.28, 168.18, 139.56, 133.90, 130.65, 130.46, 
125.54 (q, J = 279.3 Hz), 124.15, 117.24, 62.47, 55.24, 50.85, 41.04 (q, J = 28.1 Hz), 24.10, 21.09, 
13.89. 19 F NMR (471 MHz, CDCl3): -61.68. IR: ν = 2924, 2159, 1733, 1663, 1491, 1396, 1255, 
1131, 1015, 824cm-1. HRMS (ESI): calcd for C16H19F3NO3+ [M+H]+: 330.1317; found: 330.1315.
Ethyl 1-acetyl-5-butyl-3-(2,2,2-trifluoroethyl)indoline-3-
carboxylate (4f). White solid, 79mg, 71%. 1H NMR (400 MHz, 
CDCl3): δ 8.08 (d, J = 8.2 Hz, 1H), 7.14 (d, J = 1.7 Hz, 1H), 7.11 
(dd, J = 8.3, 1.8 Hz, 1H), 4.84 (d, J = 11.2 Hz, 1H), 4.20 (qd, J = 
7.1, 1.9 Hz, 2H), 4.03 (d, J = 11.1 Hz, 1H), 3.35 (dq, J = 15.3, 10.8 
Hz, 1H), 2.58 (t, J = 7.7 Hz, 2H), 2.56 – 2.46 (m, 1H), 2.28 (s, 3H), 
1.62 – 1.50 (m, 2H), 1.34 (p, J = 7.4 Hz, 2H), 1.26 (t, J = 7.1 Hz, 
3H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3): 170.25, 
168.16, 139.71, 139.06, 130.35, 130.09, 125.57 (q, J = 278.7 Hz), 123.52, 117.22, 62.38, 55.30, 
50.89, 40.99 (q, J = 28.0 Hz), 35.23, 33.77, 24.06, 22.20, 13.91, 13.87. 19 F NMR (471 MHz, 
CDCl3): -61.75. IR: ν = 2957, 2928, 2859, 1735, 1666, 1491, 1399, 1255, 1131, 1014, 834cm-1. 
HRMS (ESI): calcd for C19H25F3NO3+ [M+H]+: 372.1787; found: 372.1779.
3-Ethyl 1-methyl 3-(2,2,2-trifluoroethyl)indoline-1,3-dicarboxylate 
(4g). White solid, 71.5mg, 72%. 1H NMR (400 MHz, CDCl3): δ 7.90 
(s, 1H), 7.34 (dd, J = 7.7, 1.2 Hz, 1H), 7.29 (d, J = 7.8 Hz, 1H), 7.02 (td, 
J = 7.6, 1.1 Hz, 1H), 4.83 (d, J = 12.0 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 
4.03 (d, J = 12.5 Hz, 1H), 3.86 (s, 3H), 3.29 (dq, J = 15.2, 10.7 Hz, 1H), 
2.54 (dq, J = 15.2, 10.1 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 
MHz, CDCl3): 170.42, 153.15, 141.68, 130.06, 125.49 (q, J = 278.7Hz), 
124.11, 123.06, 115.26, 62.34, 53.89, 52.82, 50.48, 41.25 (q, J = 28.2 Hz), 13.88. 19 F NMR (471 
MHz, CDCl3): -61.52. IR: ν = 2959, 1712, 1487, 1443, 1396, 1254, 1217, 1130, 1064, 1015, 751cm-1. 
HRMS (ESI): calcd for C15H17F3NO4+ [M+H]+: 332.1110; found: 332.1107.
1-Tert-butyl 3-ethyl 3-(2,2,2-trifluoroethyl)indoline-1,3-dicarboxylate 
(4h). White solid, 80.5mg, 72%. 1H NMR (400 MHz, CDCl3): δ 7.87 
(s, 1H), 7.32 (dd, J = 7.7, 1.3 Hz, 1H), 7.30 – 7.25 (m, 1H), 6.98 (td, J = 
7.5, 1.1 Hz, 1H), 4.76 (d, J = 12.1 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 
3.99 (d, J = 12.1 Hz, 1H), 3.27 (dq, J = 15.2, 10.7 Hz, 1H), 2.54 (dq, J 
= 15.2, 10.1 Hz, 1H), 1.58 (s, 9H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR 
(101 MHz, CDCl3): 170.61, 151.99, 129.93, 125.52 (q, J = 278.5 Hz), 
123.99, 122.60, 62.26, 54.05, 54.02, 41.32 (q, J = 28.0 Hz), 28.41, 13.90 19 F NMR (471 MHz, 
CDCl3): -61.64. IR: ν = 2982, 2161, 1704, 1485, 1392, 1254, 1130, 1018, 751cm-1. HRMS (ESI): 
calcd for C18H23F3NO4+ [M+H]+: 374.1579; found: 374.1580.
2,4-Dimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-1,3(2H,4H)-dione 
(6a). White solid, 54mg, 66%. 1H NMR (400 MHz, CDCl3): δ 8.29 
























8.1, 7.4, 1.1 Hz, 1H), 7.43 (dd, J = 7.9, 1.2 Hz, 1H), 3.41 (s, 3H), 3.41 – 3.28 (m, 1H), 2.81 (dq, J = 
15.1, 9.8 Hz, 1H), 1.67 (s, 3H). 13C NMR (101 MHz, CDCl3): 174.57, 163.74, 140.37, 133.82, 
129.30, 128.07, 125.65, 124.22, 123.58, 44.76, 44.49, 44.22, 43.57, 43.55, 31.18, 27.42.[8]
2,4,6-Trimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-1,3(2H,4H)-dione 
(6b). White solid, 59mg, 69%. 1H NMR (400 MHz, CDCl3): δ 8.16 
(d, J = 8.0 Hz, 1H), 7.31 – 7.26 (m, 1H), 7.20 (s, 1H), 3.40 (s, 3H), 3.33 
(dq, J = 15.1, 9.7 Hz, 1H), 2.79 (dq, J = 15.1, 9.7 Hz, 1H), 2.46 (s, 3H), 
1.65 (s, 3H).13C NMR (101 MHz, CDCl3): 174.73, 163.78, 144.75, 
140.39, 129.30, 129.17, 126.00, 124.99 (q, J = 278.8 Hz), 121.74, 44.33 
(q, J = 27.7 Hz), 43.49 (q, J = 2.1 Hz), 31.20, 27.33, 21.93.[8]
2,4,8-Trimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-1,3(2H,4H)-dione 
(6c). White solid, 62mg, 72%. 1H NMR (400 MHz, CDCl3): δ 7.50 (t, J 
= 7.7 Hz, 1H), 7.33 – 7.25 (m, 2H), 3.30-3.41 (m, 4H), 2.87 – 2.68 (m, 
4H), 1.66 (s, 3H). 13C NMR (101 MHz, CDCl3): 174.26, 164.24, 143.04, 
141.70, 132.58, 132.06, 125.05 (q, J = 278.7 Hz), 123.96, 122.56, 44.66 
(q, J = 27.7 Hz), 43.60 (q, J = 2.5 Hz), 31.63, 27.40, 24.11.[9]
6-Methoxy-2,4-dimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-
1,3(2H,4H)-dione (6d). White solid, 40mg, 44%. 1H NMR 
(400 MHz, CDCl3): δ 8.24 (d, J = 8.8 Hz, 1H), 7.00 (dd, J = 8.8, 
2.4 Hz, 1H), 6.85 (d, J = 2.4 Hz, 1H), 3.91 (s, 3H), 3.39 (s, 3H), 
3.33 (dq, J = 15.1, 9.7 Hz, 1H), 2.76 (dq, J = 15.1, 9.7 Hz, 1H), 
1.65 (s, 3H). 13C NMR (101 MHz, CDCl3): 174.64, 163.97, 
163.40, 142.57, 131.68, 124.97 (q, J = 278.8 Hz), 117.23, 113.60, 
111.16, 55.64, 44.41 (q, J = 27.5 Hz), 43.74 (q, J = 2.4 Hz), 31.30, 27.28.[9]
6-Chloro-2,4-dimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-
1,3(2H,4H)-dione (6e). White solid, 61mg, 67%. 1H NMR (400 
MHz, CDCl3): δ 8.23 (d, J = 8.4 Hz, 1H), 7.47 (dd, J = 8.5, 2.0 Hz, 
1H), 7.41 (d, J = 2.0 Hz, 1H), 3.40 (s, 3H), 3.39 – 3.29 (dq, J = 
15.2, 9.7 Hz, 1H), 2.77 (dq, J = 15.2, 9.7 Hz, 1H), 1.67 (s, 3H). 
13C NMR (101 MHz, CDCl3): 173.91, 162.90, 142.06, 140.51, 
130.92, 128.78, 125.90, 124.81 (q, J = 278.5 Hz), 122.76, 44.40 
(q, J = 27.7 Hz), 43.57 (q, J = 2.4 Hz), 31.01, 27.51.[9]
6-Bromo-2,4-dimethyl-4-(2,2,2-trifluoroethyl)isoquinoline-
1,3(2H,4H)-dione (6f). White solid, 51mg, 49%. 1H NMR 
(400 MHz, CDCl3): δ 8.15 (d, J = 8.4 Hz, 1H), 7.63 (dd, J = 8.5, 
1.8 Hz, 1H), 7.58 (d, J = 1.8 Hz, 1H), 3.40 (s, 3H), 3.35 (dq, J = 
15.1, 9.6 Hz, 1H), 2.77 (dq, J = 15.1, 9.6 Hz, 1H), 1.67 (s, 3H). 





























130.91, 129.09, 128.90, 124.81 (q, J = 278.5 Hz), 123.18, 44.40 (q, J = 27.6 Hz), 43.51 (q, J = 1.7 
Hz), 31.01, 27.52.[9]
2,4-Dimethyl-4-(2,2,2-trifluoroethyl)-6-
(trifluoromethyl)isoquinoline-1,3(2H,4H)-dione (6g). White 
solid, 42mg, 41%. 1H NMR (400 MHz, CDCl3): δ 8.43 (d, J 
= 8.2 Hz, 1H), 7.75 (dd, J = 8.3, 1.6 Hz, 1H), 7.67 (s, 1H), 3.48 
– 3.35 (m, 4H), 2.83 (dq, J = 15.2, 9.6 Hz, 1H), 1.70 (s, 3H). 
13C NMR (101 MHz, CDCl3): 173.75, 162.58, 135.46 (q, J = 
32.9 Hz), 130.25, 127.15, 124.91 (q, J = 3.2 Hz), 124.76 (q, J 
= 278.7 Hz), 123.23 (q, J = 273.3 Hz), 122.85 (q, J = 3.9 Hz), 
44.40 (q, J = 27.7 Hz), 43.70 (q, J = 1.9 Hz), 31.00, 27.65.[9]
Ethyl 1-acetyl-5-fluoro-3-(2,2,2-trifluoroethyl)indoline-3-
carboxylate (6h). White solid, 44mg, 46%. 1H NMR (400 MHz, 
CDCl3): δ 8.18 (dd, J = 7.7, 1.5 Hz, 1H), 7.50 (td, J = 7.5, 1.7 Hz, 
1H), 7.45 (td, J = 7.5, 1.5 Hz, 1H), 7.38 (dd, J = 7.8, 1.3 Hz, 1H), 
4.30 (q, J = 7.1 Hz, 2H), 4.21 (d, J = 13.4 Hz, 1H), 3.60 (d, J = 13.4 
Hz, 1H), 3.27 – 3.10 (m, 4H), 2.60 (dq, J = 15.4, 10.1 Hz, 1H), 1.31 
(t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): 170.26, 163.41, 
137.75, 132.37, 129.41, 128.78, 128.28, 125.32 (q, J = 278.8 Hz), 
124.31, 62.43, 51.50, 46.54 (q, J = 1.6 Hz), 39.40 (q, J = 28.6 Hz), 35.01, 13.94.19F NMR (471 
MHz, CDCl3): -60.99. IR: ν = 2984, 2159, 1732, 1657, 1258, 1222, 1178, 1131, 1094, 700cm-1. 
HRMS (ESI): calcd for C15H17F3NO3+ [M+H]+: 316.1160; found: 316.1158.
(6aR,11bR)-5,6a-dimethyl-11b-(2,2,2-trifluoroethyl)-5,6a,7,11b-
tetrahydro-6H-indeno[2,1-c]quinolin-6-one (8). White solid, 
33mg, 32%. 1H NMR (400 MHz, CDCl3): δ 7.43 (d, J = 7.5 Hz, 
1H), 7.36 – 7.31 (m, 1H), 7.25 – 7.18 (m, 3H), 7.04 (dd, J = 7.9, 1.5 
Hz, 1H), 6.99 (dd, J = 8.3, 1.1 Hz, 1H), 6.93 (td, J = 7.5, 1.1 Hz, 1H), 
3.45 (s, 3H), 3.09 (d, J = 15.1 Hz, 1H), 2.98 (dq, J = 15.4, 11.1 Hz, 
1H), 2.78 (d, J = 15.1 Hz, 1H), 2.70 (dq, J = 15.4, 10.3 Hz, 1H), 1.35 
(s, 3H). 13C NMR (101 MHz, CDCl3): 172.23, 146.54, 140.83, 139.49, 
129.31, 128.23, 127.57, 126.80, 126.18 (q, J = 278.3 Hz), 125.38, 124.58, 123.39, 123.09, 114.57, 
52.68, 52.56, 44.42, 39.29 (q, J = 27.5 Hz), 30.17, 18.69. HRMS (ESI): calcd for C20H19F3NO3+ 































cv 3.5 V, 8 F/mol
undivided cell, in air
Procedure for the gram scale electrochemical experiments: To a 50 mL beaker with a stir bar was 
charged with 7 mmol 1a, 10.5 mmol Langlois reagent and 0.35 mmol MnBr2, followed by 30 mL 
dioxane, 3 mL H2O, and 14 mmol H3PO4. Two electrodes (Graphite SK-50 used as the anode and 
Platinum as the cathode) were set up in the beaker. The resulting mixture was electrolyzed at 
constant voltage mode with 3.5 V under 60 oC. After 4 F/mol electric quantity, another 10.5 mmol 
Langlois reagent was added. After a total of 8 F/mol electric quantity, the reaction mixture was 
concentrated under reduced pressure. The residue was chromatographed through silica gel eluting 
with PE/EA to give the desired product 2a.
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6. X-ray single crystal data
Crystal structure data of 4d:
13
CCDC number: 1890462
Bond precision: C-C = 0.0048 A Wavelength=0.71073





Space group P 21/c P 21/c
Hall group -P 2ybc -P 2ybc
Moiety formula C15 H15 Br F3 N O3 ?
Sum formula C15 H15 Br F3 N O3 C15 H15 Br F3 N O3
Mr 394.18 394.19
Dx,g cm-3 1.613 1.613
Z 4 4







Correction method= # Reported T Limits: Tmin=0.540 Tmax=1.000
AbsCorr = MULTI-SCAN
14
Data completeness= 0.998 Theta(max)= 27.484
R(reflections)= 0.0484( 2170) wR2(reflections)= 0.1342( 3713)
S = 1.032 Npar= 210
Crystal structure data of 8:
CCDC number: 1885350
Bond precision: C-C = 0.0054 A Wavelength=1.54184





Space group P -1 P -1
Hall group -P 1 -P 1
Moiety formula C20 H18 F3 N O ?
Sum formula C20 H18 F3 N O C20 H18 F3 N O
Mr 345.35 345.35
Dx,g cm-3 1.379 1.379
Z 4 4








Correction method= # Reported T Limits: Tmin=0.551 Tmax=1.000
AbsCorr = MULTI-SCAN
Data completeness= 0.998 Theta(max)= 66.594
R(reflections)= 0.0700( 4423) wR2(reflections)= 0.1837( 5863)
S = 1.067 Npar= 456
16
7. 1H NMR, 13C NMR and 19F NMR Spectra 
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